CSM(B) recommended the grant of a product licence for Hemofil.

Linked evidence

DHSC0105593_003 - Appendix A - Committee on Safety of Medicines - Consideration of applications for clinical trial certificates and product licences - 10 Jan 1973

Chronology Information

Date:

10 January 1973

Chapter/issue

Blood Products and Addressing Risk: Regulation of Commercial Factor Concentrates